Trial intelligence / Profile preview

Triticum aestivum for vascular function in Mexican obese patients

NCT06950138Phase 3Completed

Sponsor
Coordinación de Investigación en Salud
Start
Jan 2023
Primary completion
Jan 2025
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial in obesity and vascular dysfunction, sponsored by Coordinación de Investigación en Salud. Primary endpoints: Wave Pulse Velocity at 12 weeks and Flow-mediated dilatation at 12 weeks. Started Jan 2023; status: completed.

02

Conditions

obesityvascular dysfunction

Beyond the preview

Go deeper on NCT06950138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06950138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call